Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial (Q35039951)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial (English)

1 reference

Europe PubMed Central

5 August 2017

(RS)-rabeprazole

0 references

author name string

Bhupesh Dewan

1

1 reference

Europe PubMed Central

5 August 2017

Nisha Philipose

2

1 reference

Europe PubMed Central

5 August 2017

publication date

5 May 2011

1 reference

Europe PubMed Central

5 August 2017

Gastroenterology research and practice

1 reference

Europe PubMed Central

5 August 2017

2011

1 reference

Europe PubMed Central

5 August 2017

640685

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Epidemiology of functional dyspepsia: a global perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Helicobacter pylori infection in India: the case against eradication.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Guidelines for the management of dyspepsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Evaluation and treatment of dyspepsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Effect of lafutidine, a histamine H2-receptor antagonist, on gastric mucosal blood flow and duodenal HCO3- secretion in rats: relation to capsaicin-sensitive afferent neurons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Dyspepsia: management guidelines for the millennium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Interaction of endogenous nitric oxide and CGRP in sensory neuron-induced gastric vasodilation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Effect of daily oral omeprazole on 24 hour intragastric acidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

8 July 2018

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

Potent and long-lasting action of lafutidine on the human histamine H(2) receptor

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting?

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F640685

21 January 2018

Epidemiology of dyspepsia in the general population in Mumbai.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113257

25 October 2018

Lafutidine-induced stimulation of mucin biosynthesis mediated by nitric oxide is limited to the surface mucous cells of rat gastric oxyntic mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lafutidine changes levels of somatostatin, calcitonin gene-related peptide, and secretin in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2011/640685

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35039951&oldid=1808021262"